
- Oncology
- Current
Developing novel medicines using chemoproteomics and machine learning to accelerate therapies to drug previously considered “undruggable” targets driving human disease, starting with cancer
frontiermeds.comDeveloping novel medicines using chemoproteomics and machine learning to accelerate therapies to drug previously considered “undruggable” targets driving human disease, starting with cancer
frontiermeds.com